Skip to main content

CORRECTION article

Front. Med., 07 December 2023
Sec. Translational Medicine
Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1338616

Corrigendum: Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers–Danlos syndrome

Antonio Bulbena1,2* Silvia Rosado2,3 Marina Cabaleiro1,2 María Martinez1,2 Carolina Baeza-Velasco4,5,6 Luis-Miguel Martin2 Santiago Batlle2 Andrea Bulbena-Cabré7
  • 1Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain
  • 2Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain
  • 3Doctorate Program in Psychiatry, Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain
  • 4Laboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, Paris, France
  • 5Department of Emergency Psychiatry and Acute Care, CHU Montpellier, Montpellier, France
  • 6Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France
  • 7Icahn School of Medicine, Mount Sinai, New York, NY, United States

A corrigendum on
Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers–Danlos syndrome

by Bulbena, A., Rosado, S., Cabaleiro, M., Martinez, M., Baeza-Velasco, C., Martin, L.-M., Batlle, S., and Bulbena-Cabré, A. (2023). Front Med. 10:1039223. doi: 10.3389/fmed.2023.1039223

In the published article, there was an error regarding the affiliations for Silvia Rosado. As well as having affiliation 2, they should also have “Doctorate Program in Psychiatry, Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain”. Silvia Rosado's affiliations are now 2 and 3.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Ehlers-Danlos syndrome, anxiety, psychosomatic medicine, reliability, validity, joint hypermobility, neuroconnective endophenotype

Citation: Bulbena A, Rosado S, Cabaleiro M, Martinez M, Baeza-Velasco C, Martin L-M, Batlle S and Bulbena-Cabré A (2023) Corrigendum: Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers–Danlos syndrome. Front. Med. 10:1338616. doi: 10.3389/fmed.2023.1338616

Received: 14 November 2023; Accepted: 27 November 2023;
Published: 07 December 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Bulbena, Rosado, Cabaleiro, Martinez, Baeza-Velasco, Martin, Batlle and Bulbena-Cabré. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Antonio Bulbena, abulbena@gmail.com

Download